Genomics

Dataset Information

0

Aquaporin gene therapy corrects Sjogren's syndrome phenotype in mice


ABSTRACT: Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease that is estimated to affect 35 million people worldwide. Currently, no effective treatments exist for Sjögren’s syndrome, and there is a limited understanding of the physiological mechanisms associated with xerostomia and hyposalivation. The present work revealed that aquaporin 5 expression, a water channel critical for salivary gland fluid secretion, is regulated by bone morphogenetic protein 6. In- creased expression of this cytokine is strongly associated with the most common symptom of primary Sjögren’s syndrome, the loss of salivary gland function. This finding led us to develop a novel ther- apy in the treatment of Sjögren’s syndrome by increasing the water permeability of the gland to restore saliva flow. Our study demon- strates that the targeted increase of gland permeability not only resulted in the restoration of secretory gland function but also re- solved the hallmark salivary gland inflammation and systemic inflam- mation associated with disease. Secretory function also increased in the lacrimal gland, suggesting this local therapy could treat the sys- temic symptoms associated with primary Sjögren’s syndrome.

ORGANISM(S): Homo sapiens

PROVIDER: GSE80225 | GEO | 2016/07/20

SECONDARY ACCESSION(S): PRJNA318351

REPOSITORIES: GEO

Similar Datasets

2017-07-29 | GSE102020 | GEO
2009-04-11 | E-GEOD-15640 | biostudies-arrayexpress
2022-01-05 | GSE180544 | GEO
2021-09-13 | E-MTAB-10517 | biostudies-arrayexpress
2021-11-16 | GSE188478 | GEO
2012-09-06 | E-GEOD-40611 | biostudies-arrayexpress
2021-04-17 | E-MTAB-10339 | biostudies-arrayexpress
2017-02-28 | PXD002468 | Pride
2020-07-09 | PXD016231 | Pride
2024-01-01 | GSE234789 | GEO